Board of Trustees

The Board of Trustees of Max Planck Florida Institute for Neuroscience is a group of dedicated professionals representing a variety of backgrounds and expertise. The Board actively participates in the guidance of the Institute towards fulfilling its mission while maintaining the highest standards of accountability.

As a public not-for-profit institution, the Institute takes seriously its responsibilities to maintain public trust and to integrate sound business practices into its daily operations. The Board reviews the Institute’s activities and progress towards its fundamental goal of conducting basic research to stimulate novel approaches in understanding the structure, function and development of neural circuits.

Dr. David C. Auth, PhD, PE, NAE
Affiliate Professor of Bioengineering, University of Washington

Alex W. Dreyfoos
Chairman, The Dreyfoos Group

George Elmore
President, Hardrives, Inc.

Judge Louis J. Freeh
Chairman, Freeh Group International Solutions, LLC
Partner & past Chair, Executive Committee, Pepper Hamilton LLP

Dr. Jean-Pierre Garnier, PhD
Chairman, Actelion Ltd.
Operating Partner at Advent International

Professor Dr. Peter Gruss – Chairman
President, Max Planck Society for the Advancement of Science (2002-2014)

Professor Dr. Bill Hansson
Vice President, Max Planck Society for the Advancement of Science
Director, Max Planck Institute for Chemical Ecology

Nasser J. Kazeminy
Chairman, NJK Holding Corporation

Ms. Bonnie McElveen-Hunter
CEO & Owner, Pace Communications
Chairman, American Red Cross

James R. Mellor
Chairman, USEC Inc.
Retired Chairman & Chief Executive Officer, General Dynamics Corporation

Bernard Poussot
Retired Chairman, CEO & President, Wyeth

Dr. Carla J. Shatz
Sapp Family Provostial Professor
Professor of Biology and Neurobiology
David Starr Jordan Director, Stanford Bio-X